67: Yes To Life Show with Robin Daly - Episode 6767: Yes To Life Show with Robin Daly - Episode 67
UK Health Radio Podcast
Jay Kulsh discusses the potential of electrotherapy in cancer treatment with Robin Daly on the Yes to Life show.
44:03•27 Mar 2024
Electrotherapy: A New Frontier in Cancer Treatment with Jay Kulsh
Episode Overview
- Jay Kulsh introduces the concept of electrotherapy and its potential in disrupting cancer growth at a critical enzyme level.
- Discussion on the practical application of electrotherapy for surface tumors and the process involved.
- Insights on the challenges faced by Jay in gaining recognition for his innovative approach in cancer treatment.
- Patient success stories and the impact of electrotherapy on various individuals with cancer.
- Exploration of the global impact and potential benefits of integrating electrotherapy into mainstream cancer care.
“Well, in the cell cancer growth process, the most critical enzyme is this ribonucleotide reductase. It converts the building blocks of RNA into those of DNA. And RNA is used for so many purposes, so those building blocks are always there.”
Imagine a world where cancer treatment doesn't solely rely on traditional methods. In this eye-opening episode of the Yes to Life show, host Robin Daly sits down with Jay Kulsh, a pioneer who has dedicated over 30 years to advocating for electrotherapy in cancer care. Jay’s passion and persistence have led him to push for the formal recognition and trialling of this promising technique, which targets a crucial enzyme to disrupt cancer growth.
His insights offer a refreshing look at alternative approaches in the fight against cancer. Whether you're a patient, a caregiver, or simply curious about innovative medical treatments, this episode provides valuable perspectives that could reshape your understanding of cancer therapy.

Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.
